The University of Chicago Header Logo

Connection

Jill De Jong to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Back to Details
This is a "connection" page, showing publications Jill De Jong has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
Jill De Jong
Connection Strength
0.120
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  1. Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females. Vaccine. 2016 Jan 02; 34(1):172-8.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.